File(s) stored somewhere else
Please note: Linked content is NOT stored on University of Illinois at Chicago and we can't guarantee its availability, quality, security or accept any liability.
Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling
journal contributionposted on 06.05.2022, 17:19 by Hyun LeeHyun Lee, Jinhong Ren, Russell PesaventoRussell Pesavento, Isabel Ojeda, Amy J Rice, Haining Lv, Youngjin Kwon, Michael JohnsonMichael Johnson
The development of new therapeutic agents against the coronavirus causing Middle East Respiratory Syndrome (MERS) is a continuing imperative. The initial MERS-CoV epidemic was contained entirely through public health measures, but episodic cases continue, as there are currently no therapeutic agents effective in the treatment of MERS-CoV, although multiple strategies have been proposed. In this study, we screened 30,000 compounds from three different compound libraries against one of the essential proteases, the papain-like protease (PLpro), using a fluorescence-based enzymatic assay followed by surface plasmon resonance (SPR) direct binding analysis for hit confirmation. Mode of inhibition assays and competition SPR studies revealed two compounds to be competitive inhibitors. To improve upon the inhibitory activity of the best hit compounds, a small fragment library consisting of 352 fragments was screened in the presence of each hit compound, resulting in one fragment that enhanced the IC50 value of the best hit compound by 3-fold. Molecular docking and MM/PBSA binding energy calculations were used to predict potential binding sites, providing insight for design and synthesis of next-generation compounds.
Development of PLpro and 3CLpro Protease Inhibitors as Novel SARS Therapeutics | Funder: National Institutes of Health (National Institute of Allergy and Infectious Diseases) | Grant ID: R56AI089535
CitationLee, H., Ren, J., Pesavento, R. P., Ojeda, I., Rice, A. J., Lv, H., Kwon, Y.Johnson, M. E. (2019). Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling. Bioorganic & Medicinal Chemistry, 27(10), 1981-1989. https://doi.org/10.1016/j.bmc.2019.03.050
Read the peer-reviewed publication
Emerging Infectious DiseasesVaccine RelatedPreventionBiodefense5.1 PharmaceuticalsMiddle East Respiratory Syndrome Coronavirus (MERS-CoV)Papain-like proteaseSmall molecule inhibitorHigh-throughput screeningFragment screeningMolecular modelingBinding SitesDrug DesignElectron Spin Resonance SpectroscopyHigh-Throughput Screening AssaysHumansMiddle East Respiratory Syndrome CoronavirusMolecular Docking SimulationPeptide HydrolasesProtease InhibitorsProtein Structure, TertiarySmall Molecule LibrariesStructure-Activity RelationshipViral ProteinsMedicinal & Biomolecular ChemistryMedicinal and Biomolecular ChemistryOrganic ChemistryPharmacology and Pharmaceutical Sciences